.Pharmacolibrary.Drugs.L_AntineoplasticAndImmunomodulatingAgents.L01X_OtherAntineoplasticAgents.L01XX53_Vosaroxin.Vosaroxin

Information

name:Vosaroxin
ATC code:L01XX53
route:intravenous
n-compartments2

Vosaroxin is an experimental anticancer quinolone derivative acting as a topoisomerase II inhibitor. It was being developed for the treatment of acute myeloid leukemia (AML) but is not approved for use; development was discontinued after phase III trials did not meet efficacy endpoints.

Pharmacokinetics

Pharmacokinetic parameters in adult patients with relapsed or refractory acute myeloid leukemia after intravenous administration.

References

    Revisions

    Generated at 2025-07-21T18:21:10Z by OpenModelicaOpenModelica 1.25.1 using GenerateDoc.mos